%0 Journal Article %J Am J Med Genet A %D 2019 %T Biallelic and De Novo Variants in DONSON Reveal a Clinical Spectrum of Cell Cycle-opathies with Microcephaly, Dwarfism and Skeletal Abnormalities. %A Karaca, Ender %A Posey, Jennifer E %A Bostwick, Bret %A Liu, Pengfei %A Gezdirici, Alper %A Yesil, Gozde %A Coban Akdemir, Zeynep %A Bayram, Yavuz %A Harms, Frederike L %A Meinecke, Peter %A Alawi, Malik %A Bacino, Carlos A %A Sutton, V Reid %A Kortüm, Fanny %A Lupski, James R %X

Co-occurrence of primordial dwarfism and microcephaly together with particular skeletal findings are seen in a wide range of Mendelian syndromes including microcephaly micromelia syndrome (MMS, OMIM 251230), microcephaly, short stature, and limb abnormalities (MISSLA, OMIM 617604), and microcephalic primordial dwarfisms (MPDs). Genes associated with these syndromes encode proteins that have crucial roles in DNA replication or in other critical steps of the cell cycle that link DNA replication to cell division. We identified four unrelated families with five affected individuals having biallelic or de novo variants in DONSON presenting with a core phenotype of severe short stature (z score < -3 SD), additional skeletal abnormalities, and microcephaly. Two apparently unrelated families with identical homozygous c.631C > T p.(Arg211Cys) variant had clinical features typical of Meier-Gorlin syndrome (MGS), while two siblings with compound heterozygous c.346delG p.(Asp116Ile*62) and c.1349A > G p.(Lys450Arg) variants presented with Seckel-like phenotype. We also identified a de novo c.683G > T p.(Trp228Leu) variant in DONSON in a patient with prominent micrognathia, short stature and hypoplastic femur and tibia, clinically diagnosed with Femoral-Facial syndrome (FFS, OMIM 134780). Biallelic variants in DONSON have been recently described in individuals with microcephalic dwarfism. These studies also demonstrated that DONSON has an essential conserved role in the cell cycle. Here we describe novel biallelic and de novo variants that are associated with MGS, Seckel-like phenotype and FFS, the last of which has not been associated with any disease gene to date.

%B Am J Med Genet A %V 179 %P 2056-2066 %8 2019 Oct %G eng %N 10 %1 https://www.ncbi.nlm.nih.gov/pubmed/31407851?dopt=Abstract %R 10.1002/ajmg.a.61315 %0 Journal Article %J Ann Clin Transl Neurol %D 2019 %T Biallelic CACNA2D2 variants in epileptic encephalopathy and cerebellar atrophy. %A Punetha, Jaya %A Karaca, Ender %A Gezdirici, Alper %A Lamont, Ryan E %A Pehlivan, Davut %A Marafi, Dana %A Appendino, Juan P %A Hunter, Jill V %A Akdemir, Zeynep C %A Fatih, Jawid M %A Jhangiani, Shalini N %A Gibbs, Richard A %A Innes, A Micheil %A Posey, Jennifer E %A Lupski, James R %X

OBJECTIVE: To characterize the molecular and clinical phenotypic basis of developmental and epileptic encephalopathies caused by rare biallelic variants in CACNA2D2.

METHODS: Two affected individuals from a family with clinical features of early onset epileptic encephalopathy were recruited for exome sequencing at the Centers for Mendelian Genomics to identify their molecular diagnosis. GeneMatcher facilitated identification of a second family with a shared candidate disease gene identified through clinical gene panel-based testing.

RESULTS: Rare biallelic CACNA2D2 variants have been previously reported in three families with developmental and epileptic encephalopathy, and one family with congenital ataxia. We identified three individuals in two unrelated families with novel homozygous rare variants in CACNA2D2 with clinical features of developmental and epileptic encephalopathy and cerebellar atrophy. Family 1 includes two affected siblings with a likely damaging homozygous rare missense variant c.1778G>C; p.(Arg593Pro) in CACNA2D2. Family 2 includes a proband with a homozygous rare nonsense variant c.485_486del; p.(Tyr162Ter) in CACNA2D2. We compared clinical and molecular findings from all nine individuals reported to date and note that cerebellar atrophy is shared among all.

INTERPRETATION: Our study supports the candidacy of CACNA2D2 as a disease gene associated with a phenotypic spectrum of neurological disease that include features of developmental and epileptic encephalopathy, ataxia, and cerebellar atrophy. Age at presentation may affect apparent penetrance of neurogenetic trait manifestations and of a particular clinical neurological endophenotype, for example, seizures or ataxia.

%B Ann Clin Transl Neurol %V 6 %P 1395-1406 %8 2019 Aug %G eng %N 8 %1 https://www.ncbi.nlm.nih.gov/pubmed/31402629?dopt=Abstract %R 10.1002/acn3.50824 %0 Journal Article %J Am J Hum Genet %D 2019 %T Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy. %A van Karnebeek, Clara D M %A Ramos, Rúben J %A Wen, Xiao-Yan %A Tarailo-Graovac, Maja %A Gleeson, Joseph G %A Skrypnyk, Cristina %A Brand-Arzamendi, Koroboshka %A Karbassi, Farhad %A Issa, Mahmoud Y %A van der Lee, Robin %A Drögemöller, Britt I %A Koster, Janet %A Rousseau, Justine %A Campeau, Philippe M %A Wang, Youdong %A Cao, Feng %A Li, Meng %A Ruiter, Jos %A Ciapaite, Jolita %A Kluijtmans, Leo A J %A Willemsen, Michel A A P %A Jans, Judith J %A Ross, Colin J %A Wintjes, Liesbeth T %A Rodenburg, Richard J %A Huigen, Marleen C D G %A Jia, Zhengping %A Waterham, Hans R %A Wasserman, Wyeth W %A Wanders, Ronald J A %A Verhoeven-Duif, Nanda M %A Zaki, Maha S %A Wevers, Ron A %X

Early-infantile encephalopathies with epilepsy are devastating conditions mandating an accurate diagnosis to guide proper management. Whole-exome sequencing was used to investigate the disease etiology in four children from independent families with intellectual disability and epilepsy, revealing bi-allelic GOT2 mutations. In-depth metabolic studies in individual 1 showed low plasma serine, hypercitrullinemia, hyperlactatemia, and hyperammonemia. The epilepsy was serine and pyridoxine responsive. Functional consequences of observed mutations were tested by measuring enzyme activity and by cell and animal models. Zebrafish and mouse models were used to validate brain developmental and functional defects and to test therapeutic strategies. GOT2 encodes the mitochondrial glutamate oxaloacetate transaminase. GOT2 enzyme activity was deficient in fibroblasts with bi-allelic mutations. GOT2, a member of the malate-aspartate shuttle, plays an essential role in the intracellular NAD(H) redox balance. De novo serine biosynthesis was impaired in fibroblasts with GOT2 mutations and GOT2-knockout HEK293 cells. Correcting the highly oxidized cytosolic NAD-redox state by pyruvate supplementation restored serine biosynthesis in GOT2-deficient cells. Knockdown of got2a in zebrafish resulted in a brain developmental defect associated with seizure-like electroencephalography spikes, which could be rescued by supplying pyridoxine in embryo water. Both pyridoxine and serine synergistically rescued embryonic developmental defects in zebrafish got2a morphants. The two treated individuals reacted favorably to their treatment. Our data provide a mechanistic basis for the biochemical abnormalities in GOT2 deficiency that may also hold for other MAS defects.

%B Am J Hum Genet %V 105 %P 534-548 %8 2019 Sep 05 %G eng %N 3 %1 https://www.ncbi.nlm.nih.gov/pubmed/31422819?dopt=Abstract %R 10.1016/j.ajhg.2019.07.015